Sickle Cell Disease Trial, Recruiting NCT07442851 Sponsor: Duke University Condition: Sickle Cell Disease
Back to Sickle Cell Disease

Sickle Cell Disease Trial, Recruiting

NCT07442851
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • You have been diagnosed with sickle cell disease (any type), confirmed by lab tests
  • You can understand and speak English
  • You are 35 years old or older

Who may not be able to join:

  • You currently need oxygen to help you breathe
  • You have an unstable heart condition
  • You rely on a wheelchair to get around
  • You have been diagnosed with severe cognitive impairment (serious difficulties with memory or thinking), either recorded in your medical notes or reported by your doctor
  • You are not able to give your own consent to take part in the trial
  • You have severe vision or hearing problems that cannot be corrected (for example, with glasses or hearing aids)
  • You are currently pregnant
  • You have already been successfully treated for sickle cell disease with a stem cell transplant or gene therapy

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 26 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Charity I Oyedeji, MD, Duke University

Phone: 919-684-0628

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
Registry
ClinicalTrials.gov
Start date
8 April 2026
Est. completion
1 January 2028

Where this trial is recruiting

🇺🇸 United States

Primary endpoints

Feasibility of Randomization; Safety/Adverse Events; Acceptability; Retention in the program; Adherence

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 26 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov